awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26996629-118DF709-F017-42E1-89B5-B74D17249A9E
Q26996629-118DF709-F017-42E1-89B5-B74D17249A9E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26996629-118DF709-F017-42E1-89B5-B74D17249A9E
Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma
P2860
Q26996629-118DF709-F017-42E1-89B5-B74D17249A9E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26996629-118DF709-F017-42E1-89B5-B74D17249A9E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5feca11a41122f3a8dba13e3376c75864e55ab4f
P2860
Phase II, randomized, controlled, double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage IV metastatic melanoma.